caffeine has been researched along with naproxen in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (5.66) | 18.7374 |
1990's | 5 (9.43) | 18.2507 |
2000's | 14 (26.42) | 29.6817 |
2010's | 26 (49.06) | 24.3611 |
2020's | 5 (9.43) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Jolivette, LJ; Ward, KW | 1 |
Carrupt, PA; Martel, S; Ottaviani, G | 2 |
Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Akamatsu, M | 1 |
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Caradonna, NP; Hallifax, D; Houston, JB; Turlizzi, E; Zanelli, U | 1 |
Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Saadah, HA | 1 |
Hering, R; Steiner, TJ | 1 |
Liu, XD; Shi, QH; Wang, JJ; Zhang, JH | 1 |
Baumel, B; Diamond, S; Eisner, LS; Peters, K; Saper, JR; Sargent, JD; Solbach, P | 1 |
Buttram, VC; Gravlee, LC; Hale, RW; Lifshitz, S | 1 |
Hoyo-Vadillo, C; López-Munoz, FJ; Pérez-Urizar, J | 1 |
Garcia, I; Hoyo-Vadillo, C; Lopez-Muñoz, FJ; Perez-Urizar, JT; Terron, JA; Villalon, CM | 1 |
Bebawy, LI; El-Kousy, NM | 1 |
Foster, GD; Thomas, PM | 1 |
Hancock, DB; Jewett, R; Martin, ER; Scott, BL; Scott, WK; Stacy, MA; Stajich, JM; Vance, JM | 1 |
Del Bene, E; Di Loreto, G; Di Trapani, G; Dionisio, P; Granella, F; LaPegna, G; Pini, LA; Prudenzano, MP; Sarchielli, P; Savi, L; Zanchin, G | 1 |
Barker, SA | 1 |
Abbott, PV; Asgar, K; Delvarani, A; Karamifar, K; Khabazi, H; Kharazifard, MJ; Lotfi, M; Mehrvarzfar, P; Saghiri, MA | 1 |
Fox, AW | 1 |
Choi, DJ; Her, N; Kim, SK; Nam, SW; Zoh, KD | 1 |
Mahugo-Santana, C; Montesdeoca-Esponda, S; Santana-Rodríguez, JJ; Sosa-Ferrera, Z | 1 |
Hu, Z; Lam, JC; Lam, PK; Lin, B; Lyu, J; Lyu, XJ; Yu, HQ | 1 |
Abd, E; Grice, JE; Mohammed, YH; Namjoshi, S; Roberts, MS | 1 |
de Bustamante, I; Herrera López, S; Martínez-Hernández, V; Meffe, R | 1 |
Groza, LG; Hebig, KH; Ptacek, CJ; Sabourin, MJ; Scheytt, TJ | 1 |
de Bustamante, I; Kohfahl, C; Martínez-Hernández, V; Meffe, R | 1 |
Anoopkumar-Dukie, S; Arora, D; Grant, GD; Hall, S; Kinra, M; Mallik, SB; Mudgal, J; Nampoothiri, M; Rao, CM | 1 |
Abd, E; Benson, HAE; Grice, JE; Mohammed, YH; Roberts, MS | 1 |
Escher, BI; Müller, RA; Nivala, J; Reemtsma, T; Schlichting, R; Sossalla, NA; van Afferden, M | 1 |
Doolaanea, AA; Kumar, M; Mandal, UK; Singh, S | 1 |
Abdool-Ghany, AA; Gidley, ML; Klaus, J; Sahwell, PJ; Sinigalliano, CD; Solo-Gabriele, HM | 1 |
Lau, CI; Wang, YF | 1 |
Lindahl, E; Lundborg, M; Norlén, L; Wennberg, C | 1 |
1 review(s) available for caffeine and naproxen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for caffeine and naproxen
Article | Year |
---|---|
Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs.
Topics: Adult; Amitriptyline; Analgesics; Caffeine; Ergotamine; Evaluation Studies as Topic; Female; Follow-Up Studies; Headache; Humans; Male; Middle Aged; Migraine Disorders; Naproxen; Outpatients; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
Aborting a migraine attack: naproxen sodium v ergotamine plus caffeine.
Topics: Adolescent; Adult; Caffeine; Clinical Trials as Topic; Drug Combinations; Ergotamine; Ergotamines; Female; Humans; Male; Middle Aged; Migraine Disorders; Naproxen | 1988 |
Naproxen sodium vs. a combination of aspirin, phenacetin, caffeine and codeine phosphate for pain after major gynecologic surgery. A multicenter comparison.
Topics: Aspirin; Caffeine; Clinical Trials as Topic; Codeine; Double-Blind Method; Drug Combinations; Female; Genital Diseases, Female; Humans; Hysterectomy; Infertility, Female; Naproxen; Pain, Postoperative; Phenacetin | 1984 |
Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium.
Topics: Acetaminophen; Adolescent; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Central Nervous System Stimulants; Cross-Over Studies; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Italy; Male; Middle Aged; Naproxen; Pain Measurement; Pain Threshold; Retrospective Studies; Tension-Type Headache; Young Adult | 2008 |
Effects of three oral analgesics on postoperative pain following root canal preparation: a controlled clinical trial.
Topics: Acetaminophen; Administration, Oral; Adult; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Pain Measurement; Pain, Postoperative; Placebos; Pulpectomy; Pulpitis; Root Canal Preparation; Tramadol; Young Adult | 2012 |
Efficacy, end points and eventualities: sumatriptan/naproxen versus butalbital/paracetamol/caffeine in the treatment of migraine.
Topics: Acetaminophen; Barbiturates; Caffeine; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Endpoint Determination; Humans; Migraine Disorders; Naproxen; Severity of Illness Index; Sumatriptan; Treatment Outcome | 2012 |
46 other study(ies) available for caffeine and naproxen
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability.
Topics: 1-Octanol; Diffusion; Dimethylpolysiloxanes; Humans; In Vitro Techniques; Membranes, Artificial; Myristates; Permeability; Skin; Skin Absorption; Water | 2006 |
In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities.
Topics: Humans; Membranes, Artificial; Models, Biological; Models, Molecular; Octanols; Permeability; Pharmaceutical Preparations; Skin Absorption; Water | 2007 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs.
Topics: Cell Line, Tumor; Cryopreservation; Female; Hepatocytes; Humans; Male; Metabolic Clearance Rate; Pharmaceutical Preparations; Predictive Value of Tests | 2012 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine.
Topics: Adult; Caffeine; Drug Combinations; Ergotamine; Humans; Metoclopramide; Middle Aged; Migraine Disorders; Naproxen; Retrospective Studies | 1992 |
[Spectrophotometric determination of complex formation constants of naproxen with caffeine, nicotinamide and salicylic acid in aqueous solution].
Topics: Caffeine; Ligands; Naproxen; Niacinamide; Salicylates; Solutions; Spectrophotometry, Ultraviolet | 1989 |
Usefulness of the pain-induced functional impairment model to relate plasma levels of analgesics to their efficacy in rats.
Topics: Analgesics; Animals; Caffeine; Drug Interactions; Female; Movement Disorders; Naproxen; Pain Measurement; Rats; Rats, Wistar; Uric Acid | 1995 |
Relationship between plasma levels of naproxen and analgesic efficacy in rats: synergism with caffeine.
Topics: Analgesics; Animals; Caffeine; Drug Synergism; Female; Half-Life; Naproxen; Rats; Rats, Wistar | 1994 |
Simultaneous determination of some multicomponent dosage forms by quantitative thin layer chromatography densitometric method.
Topics: Acetaminophen; Caffeine; Chlorzoxazone; Chromatography, Thin Layer; Densitometry; Diflunisal; Dosage Forms; Naproxen; Pharmaceutical Preparations; Solvents; Theophylline | 1999 |
Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process.
Topics: Caffeine; Diclofenac; Ibuprofen; Ketoprofen; Meclofenamic Acid; Models, Chemical; Naproxen; Pharmaceutical Preparations; Triclosan; Waste Disposal, Fluid; Water Pollutants, Chemical | 2005 |
Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Beverages; Caffeine; Case-Control Studies; Family Health; Female; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Odds Ratio; Parkinson Disease; Risk Factors; Smoking; Tea | 2007 |
Drug contamination of the equine racetrack environment: a preliminary examination.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Clonixin; Dust; Environmental Pollutants; Fresh Water; Gas Chromatography-Mass Spectrometry; Horses; Housing, Animal; Naproxen; Pharmaceutical Preparations; Phenylbutazone; Soil | 2008 |
Adsorption characteristics of selected hydrophilic and hydrophobic micropollutants in water using activated carbon.
Topics: 2,4-Dichlorophenoxyacetic Acid; Acetaminophen; Adsorption; Atrazine; Caffeine; Carbanilides; Carbon; Diclofenac; Endocrine Disruptors; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Naproxen; Pesticides; Pharmaceutical Preparations; Sulfamethazine; Sulfamethoxazole; Temperature; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2014 |
A dispersive liquid-liquid micellar microextraction for the determination of pharmaceutical compounds in wastewaters using ultra-high-performace liquid chromatography with DAD detection.
Topics: Caffeine; Carbamazepine; Chloroform; Chromatography, High Pressure Liquid; Ketoprofen; Liquid Phase Microextraction; Micelles; Naproxen; Ornidazole; Osmolar Concentration; Pharmaceutical Preparations; Polidocanol; Polyethylene Glycols; Solvents; Spain; Temperature; Wastewater; Water Pollutants, Chemical | 2015 |
Characterization of cefalexin degradation capabilities of two Pseudomonas strains isolated from activated sludge.
Topics: Anti-Bacterial Agents; Caffeine; Cephalexin; Chloramphenicol; Naproxen; Pseudomonas; Pyrazines; RNA, Bacterial; RNA, Ribosomal, 16S; Salicylic Acid; Sequence Analysis, RNA; Sewage; Sulfamethoxazole; Water Pollutants, Chemical | 2015 |
Synergistic Skin Penetration Enhancer and Nanoemulsion Formulations Promote the Human Epidermal Permeation of Caffeine and Naproxen.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Cyclohexanols; Diffusion Chambers, Culture; Emulsions; Epidermis; Eucalyptol; Excipients; Female; Humans; Monoterpenes; Nanostructures; Naproxen; Oleic Acid; Skin Absorption; Solubility | 2016 |
The role of sorption and biodegradation in the removal of acetaminophen, carbamazepine, caffeine, naproxen and sulfamethoxazole during soil contact: A kinetics study.
Topics: Acetaminophen; Adsorption; Biodegradation, Environmental; Caffeine; Carbamazepine; Kinetics; Models, Chemical; Naproxen; Soil; Soil Pollutants; Spain; Sulfamethoxazole; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2016 |
Transport behavior of the pharmaceutical compounds carbamazepine, sulfamethoxazole, gemfibrozil, ibuprofen, and naproxen, and the lifestyle drug caffeine, in saturated laboratory columns.
Topics: Caffeine; Carbamazepine; Filtration; Gemfibrozil; Ibuprofen; Naproxen; Ontario; Silicon Dioxide; Sulfamethoxazole; Water Pollutants, Chemical | 2017 |
Investigating natural attenuation of pharmaceuticals through unsaturated column tests.
Topics: Acetaminophen; Caffeine; Carbamazepine; Kinetics; Naproxen; Nonlinear Dynamics; Pharmaceutical Preparations; Soil; Soil Pollutants; Sulfamethoxazole; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical | 2017 |
Interplay between adenosine receptor antagonist and cyclooxygenase inhibitor in haloperidol-induced extrapyramidal effects in mice.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Caffeine; Catalepsy; Cyclooxygenase Inhibitors; Haloperidol; Male; Mice; Motor Activity; Naproxen; Purinergic P1 Receptor Antagonists; Treatment Outcome | 2018 |
Permeation Mechanism of Caffeine and Naproxen through in vitro Human Epidermis: Effect of Vehicles and Penetration Enhancers.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Epidermis; Ethanol; Eucalyptol; Female; Humans; Hydrogen-Ion Concentration; Naproxen; Oleic Acid; Permeability; Pharmaceutical Vehicles; Polyethylene Glycols; Skin Absorption; Sodium Dodecyl Sulfate | 2019 |
Impact of various aeration strategies on the removal of micropollutants and biological effects in aerated horizontal flow treatment wetlands.
Topics: Biological Oxygen Demand Analysis; Caffeine; Diclofenac; Escherichia coli; Naproxen; Nitrogen; Oxygen; Waste Disposal, Fluid; Wastewater; Wetlands | 2022 |
A Recent Review On 3D-Printing: Scope and Challenges with Special Focus on Pharmaceutical Field.
Topics: Acetaminophen; Aspirin; Caffeine; Chloramphenicol; Humans; Naproxen; Prednisolone; Printing, Three-Dimensional; Tablets; Technology, Pharmaceutical | 2022 |
Fecal indicator bacteria levels at a marine beach before, during, and after the COVID-19 shutdown period and associations with decomposing seaweed and human presence.
Topics: Acetaminophen; Animals; Bacteria; Bathing Beaches; Caffeine; COVID-19; Dogs; Enterococcus; Environmental Monitoring; Feces; Humans; Ibuprofen; Naproxen; Seaweed; Water; Water Microbiology | 2022 |
2022 Taiwan Guidelines for Acute Treatment of Migraine.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Antiemetics; Aspirin; Caffeine; Calcitonin Gene-Related Peptide Receptor Antagonists; Child; Diclofenac; Female; Headache; Humans; Ibuprofen; Migraine Disorders; Morphine Derivatives; Naproxen; Nasal Sprays; Pregnancy; Prochlorperazine; Taiwan; Tramadol; Tryptamines | 2022 |
Understanding Drug Skin Permeation Enhancers Using Molecular Dynamics Simulations.
Topics: Caffeine; Metronidazole; Molecular Dynamics Simulation; Naproxen; Permeability; Skin; Skin Absorption; Water | 2023 |